Early Phase Human Drug Trial to Investigate DYN101 in Participants 2 to 17 Years With Centronuclear Myopathies

Stopped The first Clinical trial with DYN101 (UNITE-CNM) was early terminated. As a consequence, Dynacure decided to not perform this study.

Conditions

• Centronuclear Myopathy

Interventions

• DRUG: DYN101

Sponsor

Dynacure